Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | PRKDC | P78527 | 5/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24936652 | 0.92 | ALOX5 (0.46) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL24936648 | 0.89 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL24936771 | 0.88 | ALOX5 (0.33) | ALOX5ATMKDM4EL3MBTL1 | |
| SCHEMBL20715125 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17614164 | 0.87 | ALOX5 (0.59) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL12996570 | 0.87 | ALOX5 (0.59) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17929484 | 0.87 | ALOX5 (0.42) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL24936770 | 0.87 | HSP90AA1 (0.34) | ALOX5ATMKDM4EL3MBTL1 | |
| SCHEMBL24936777 | 0.87 | PTGER4 (0.35) | ALOX5PRKDCATMKDM4EL3MBTL1 | |
| SCHEMBL15831355 | 0.86 | ALOX5 (0.45) | ALOX5PRKDCGGPS1PTGES2PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | HTR1D, EHD1, HTR3D | ALOX5 2107/4885PRKDC 4367/4885GGPS1 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.